We describe the case of a patient with a previously placed Port-A-Cath who was admitted to hospital for new onset of non-flushing catheter and palpitations with ventricular tachycardia. A chest X-ray and a linogram showed a Port-A-Cath fracture and distal embolization into the right ventricle resulting in ventricular tachycardia. The catheter was removed percutaneously using a Goose Neck snare with no complications and resolution of the ventricular tachycardia. The removed segment demonstrated thrombus. Prompt removal of the embolized catheter fragments should be undertaken given the subtle nature of the embolization and the potential complications.
Port-a-cath fracture, Ventricular tachycardia, Percutaneous retrieval.
Financial support: None.
Amir Ravandi Division of Cardiology and Physiology Rm Y3508 Bergen Cardiac Care Centre St. Boniface Hospital 409 Taché Avenue Winnipeg R2H 2A6 Manitoba, Canada email@example.com
Share this Article
Related Content In Devices
Current Status of Transcatheter Tricuspid Valve Therapies
Heart International. 2022;16(1):49–58 DOI: https://doi.org/10.17925/HI.2022.16.1.49
Tricuspid regurgitation (TR) is a complex disease with several independent causes. Consequently, outcomes and response to therapy vary widely. Severe or progressive TR often results in gradual right ventricular (RV) failure and is associated with poor long-term outcomes.1 Most cases of severe TR are secondary to left-sided heart disease, pulmonary hypertension or dilated cardiomyopathy, causing tricuspid […]
A Comprehensive Review of Mechanical Circulatory Support Devices
Heart International. 2022;16(1):37–48 DOI: https://doi.org/10.17925/HI.2022.16.1.37
Cardiogenic shock (CS) is a life-threatening condition characterized by cardiac pump dysfunction resulting in end-organ hypoperfusion and hypoxia.1,2 Although multiple treatment strategies have been explored in clinical trials, optimal therapy for CS is still debatable and mortality remains substantially high at around 50%.1 This need for improved treatment, together with a growing burden of patients with congestive […]
Latest Advances in Transcatheter Mitral Valve Replacement
Heart International. 2021;15(2):79–83 DOI: https://doi.org/10.17925/HI.2021.15.2.79
Transcatheter-based therapies have become central to the treatment of valvular heart disease, particularly aortic stenosis.1–5 The first transcatheter aortic valve replacement (TAVR) was performed in 2002 and, in two short decades, TAVR has become a mainstay for the treatment of aortic stenosis for all surgical risk categories.1,6–8 With the global success and adoption of TAVR, significant efforts […]
Journal articles and more to your inbox
Get the latest clinical insights from touchCARDIOSign me up!